NCT05727384View on ClinicalTrials.gov

Improving Physical Function in Older Adults Using an Anti-inflammation Drug: The RIGHT Study

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

February 28, 2026

Study Completion Date

July 31, 2026

Conditions

InflammationFrailty

Interventions

DRUG

Clazakizumab

5 mg, subcutaneous injection, every 4 weeks for 24 weeks

DRUG

Placebo

5 mg, subcutaneous injection, every 4 weeks for 24 weeks

Trial Locations (1)

15260

University of Pittsburgh, Health Studies Research Center, Pittsburgh

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

CSL Behring

INDUSTRY

lead

Anne B. Newman

OTHER